Press release
Pharmacogenomics Market Leading Companies | F. Hoffmann-la Roche, Oxford Nanopore Technologies, Thermo Fisher Scientific ̧ Illumina etc.
Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00007564?utm_source=OpenPR&utm_medium=10770
The Pharmacogenomics Market indicates that the market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021, growing at a CAGR of 10.3% during 2021-2028. The pharmacogenomics industry continues to gain strong momentum as healthcare systems shift toward personalized and data-driven treatment models. The market is witnessing substantial growth due to advancements in sequencing technologies, rising awareness among clinicians, and increasing integration of genomic data into clinical workflows.
Market Overview
Pharmacogenomics refers to the study of how genes affect a person's response to medications, enabling healthcare providers to tailor drug selection and dosage according to genetic makeup. This approach plays a crucial role in improving treatment efficiency across therapeutic areas such as oncology, neurology, cardiovascular diseases, and psychiatry.
The market is driven by the rising demand for personalized medicine, the increasing prevalence of chronic and genetic disorders, and the expanding applications of genomic sequencing technologies. Pharmaceutical and biotechnology companies are increasingly leveraging pharmacogenomic data to enhance drug discovery processes and reduce late-stage drug development failures. Additionally, growing government funding and supportive regulatory frameworks are further encouraging the adoption of pharmacogenomics in clinical and research settings.
Technological advancements such as next-generation sequencing (NGS), polymerase chain reaction (PCR), and microarray analysis are significantly improving the accuracy and speed of genetic testing. These innovations are making pharmacogenomics more accessible and cost-effective, thereby broadening its adoption across healthcare systems worldwide.
Explore full report: https://www.theinsightpartners.com/reports/pharmacogenomics-market
Market Analysis
The pharmacogenomics industry is characterized by strong innovation, strategic collaborations, and continuous R&D investments. Pharmaceutical companies are increasingly partnering with genomic testing firms and research institutions to accelerate drug development and enhance therapeutic precision.
Key market growth drivers include:
• Rising incidence of cancer and cardiovascular diseases
• Increasing focus on personalized medicine approaches
• Advancements in genomic sequencing and bioinformatics tools
• Growing demand for efficient and safer drug therapies
• Expanding clinical research activities in pharmacogenomics
Key Players in the Pharmacogenomics Market
The competitive landscape of the pharmacogenomics industry includes several established biotechnology and healthcare companies actively contributing to innovation and market expansion.
Key players include:
• F. Hoffmann-La Roche Ltd
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• QIAGEN N.V.
• Abbott Laboratories
• Agilent Technologies, Inc.
• Myriad Genetics, Inc.
• Oxford Nanopore Technologies plc
• Admera Health
• Dynamic DNA Laboratories
These companies are focusing on product innovation, strategic acquisitions, and collaborations to strengthen their market presence and expand their genomic testing portfolios.
Purchase a Copy of this report: https://www.theinsightpartners.com/buy/TIPRE00007564?utm_source=OpenPR&utm_medium=10770
Future Outlook
The future of the pharmacogenomics industry is expected to be shaped by the integration of artificial intelligence, machine learning, and big data analytics into genomic research. These technologies will enhance the interpretation of complex genetic data, enabling more accurate predictions of drug response and disease susceptibility.
Additionally, the growing adoption of companion diagnostics in drug development will further accelerate market growth. Emerging economies are expected to play a significant role in market expansion due to improving healthcare infrastructure and increasing investment in genomic research initiatives.
With continuous advancements in biotechnology and increasing emphasis on precision medicine, the pharmacogenomics sector is poised to become a cornerstone of next-generation healthcare systems, enabling more effective, individualized, and predictive treatment strategies.
Related Reports
Nanobiotechnology Market- https://www.theinsightpartners.com/reports/nanobiotechnology-market
Transplant Diagnostic Market- https://www.theinsightpartners.com/reports/transplant-diagnostic-market
Contact Us
Contact Person: Ankit Mathur
Phone: +1-646-491-9876
Email: sales@theinsightpartners.com
About Us
The Insight Partners is a leading provider of actionable market intelligence and consulting services across various industries. Our research reports combine advanced analytics, expert insights, and reliable data to help organizations identify new opportunities, optimize strategies, and achieve sustainable growth. We specialize in delivering in-depth market studies covering healthcare, technology, manufacturing, and emerging sectors.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmacogenomics Market Leading Companies | F. Hoffmann-la Roche, Oxford Nanopore Technologies, Thermo Fisher Scientific ̧ Illumina etc. here
News-ID: 4482464 • Views: …
More Releases from The Insight Partners
Biobanks Market Will Generate Booming Growth Opportunities to 2028 | Key Players …
The global biobanks market is experiencing consistent growth driven by the expanding role of biological sample repositories in healthcare research and pharmaceutical development. According to The Insight Partners, the biobanks market was valued at US$ 2,418.31 million in 2021 and is expected to reach US$ 3,758.64 million by 2028, registering a compound annual growth rate of 6.5 percent during the forecast period from 2021 to 2028. This growth trajectory highlights…
Agar-Agar Market Size is Projected to Reach US$ 624.74 Million by 2034, Register …
The agar-agar market is experiencing robust growth, driven by increasing consumer demand for plant-based food products, particularly in the food and beverage industry. Agar-agar, derived from red algae, is a versatile ingredient used in various applications ranging from food production to pharmaceuticals, cosmetics, and microbiology. The agar-agar market size is projected to reach US$ 624.74 million by 2034, up from US$ 392.55 million in 2025, registering a compound annual growth…
Wicket Mailer Envelopes and Bags Market to Reach US$ 3.08 Billion by 2034, Growi …
The wicket mailer envelopes and bags market is witnessing a steady growth trajectory. With an anticipated market size of US$ 3.08 billion by 2034, up from US$ 2.13 billion in 2025, the market is projected to register a compound annual growth rate (CAGR) of 4.2% during the forecast period of 2026 to 2034. This growth can be attributed to increasing e-commerce activity, the need for cost-effective packaging solutions, and rising…
Duodenal Endoscope Market Major Players | Olympus Corporation, Fujifilm, Hoya, M …
The global Duodenal Endoscope Market is witnessing steady growth driven by the rising burden of gastrointestinal disorders and the increasing adoption of minimally invasive diagnostic and therapeutic procedures. Duodenal endoscopes are specialized medical devices used for visualizing and treating conditions in the duodenum, playing a critical role in procedures such as endoscopic retrograde cholangiopancreatography (ERCP). As healthcare systems worldwide focus on early diagnosis and improved patient outcomes, the demand for…
More Releases for Pharmacogenomics
Pharmacogenomics - Top Companies Regional and Data Analysis
Pharmacogenomics is a branch of science, which studies the role of gene over the activity of a drugs and hence helps the refreshers in predicting the response of novel as well as previously available therapies.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00007564/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Pharmacogenomics Market are:
• F. Hoffmann-la Roche Ltd
• Abbott
• Oxford Nanopore Technologies
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• QIAGEN
• Agilent Technologies, Inc.
• Myriad Genetics, Inc.
• Admera Health
Contact Us:
If you have any queries about…
Pharmacogenomics Market worth $5.8 billion by 2028
North America region is witnessing increasing investments and research activities in the field of drug discovery and development. The need for advanced therapies due to rising rate of cancer has contributed to growth of the pharmacogenomics market.
Pharmacogenomics Market [https://www.marketsandmarkets.com/Market-Reports/pharmacogenomics-market-142682251.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $5.8 billion by 2028, growing at a CAGR of 10.6% from 2023 to…
Genetic Medicine: Unveiling the Power of Pharmacogenomics
Based on technology, the pharmacogenomics market is segmented into PCR, sequencing, microarray, gel electrophoresis, mass spectrometry, and others. The market for the PCR segment is subsegmented into real time PCR, standard PCR, and digital PCR. The PCR segment dominated the pharmacogenomics market in 2021 and is expected to register the highest CAGR during the forecast period.
Download Sample PDF Details at: https://www.theinsightpartners.com/sample/TIPRE00007564?utm_source=OpenPR&utm_medium=10776
The pharmacogenomics market is segmented on the basis of…
Complete PDF Guide On Pharmacogenomics [PDF]
According to our latest study on "Pharmacogenoics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Technology, Application, and End User," the market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is expected to grow at a CAGR of 10.3% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their…
Global Pharmacogenomics Market Size & Trends
According to a new market research report published by Global Market Estimates, the global pharmacogenomics market is projected to grow at a CAGR of 9.6% from 2023 to 2028.
The growth of the global pharmacogenomics market is driven by advancements in genomics and DNA sequencing technologies, the rising demand for personalized medicine, regulatory support from agencies like the FDA, cost-effectiveness through reduced adverse reactions, and a growing aging population with complex…
Global Pharmacogenomics Services Market Insights | 2022-2032
The Pharmacogenomics Services Market refers to the services provided by companies and laboratories that offer personalized medicine based on a patient's genetic makeup. Pharmacogenomics is the study of how an individual's genes affect their response to certain drugs, and the pharmacogenomics services market focuses on utilizing this knowledge to optimize drug therapy.
These services typically involve genetic testing to identify specific genetic variations that may impact a patient's response to certain…
